Lexatumumab Antibody
Lexatumumab (GHS-ETR2) is a human agonistic monoclonal antibody targeting TRAIL-R2 (DR5) to induce apoptosis in cancer cells. It is a research tool for studying malignant pleural mesothelioma (MPM), with demonstrated pro-apoptotic activity in both in vitro cell cultures and in vivo xenograft models.
Product Specifications
Product Name Alternative
Apoptosis, DR5 mAB, Lexatumumab, HGS-ETR 2, ETR2-ST01, TRAIL
Target
Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
4.69 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
143.48 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog